HG-67 PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPG

類似資料

• ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
  著者:: Carvalho, Diana, 等
  出版事項: (2019)
• DIPG-29. PRECLINICAL EFFICACY OF COMBINED ACVR1 AND PI3K/mTOR INHIBITION IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
  著者:: Carvalho, Diana, 等
  出版事項: (2018)
• ACVR1 mutations in DIPG: lessons learned from FOP
  著者:: Taylor, Kathryn R, 等
  出版事項: (2014)
• HG-96 FUNCTIONAL INTEGRITY OF THE BLOOD-BRAIN BARRIER IN H3.3K27M DIPG XENOGRAFTS
  著者:: Olaciregui, Nagore G., 等
  出版事項: (2016)
• HG-72 DIPG CELLS ESCAPE THE PONS EARLY DURING TUMOUR EVOLUTION
  著者:: Vinci, Mara, 等
  出版事項: (2016)